Herceptin (trastuzumab) Intravenous Infusion
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
WARNINGS AND PRECAUTIONS
Embryo-Fetal Toxicity
Verify the pregnancy status of females of reproductive potential prior...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts